Table 1.

Genes with significant prognostic value in hepatocellular carcinoma identified in both The Cancer Genome Atlas and Integrative Molecular Database of Hepatocellular Carcinoma

Times of gene verification by HCC cohorts from HCCDB	Down-regulated gene in low score group	Up-regulated gene in low score group
2	MS4A1, KLRB1, ITK, GZMH, ADH1C, UGT2B15, GPR171, CD40LG, CD5, FBLN2, CCL21, ATP2A3, IL16, ELN
1	SELL, CD5L, KLRK1, CXCR6, TRAF3IP3, CD79A, FLT3, GZMA, SPN, PRKCQ, SIDT1, RERGL, INMT, C11orf21, ZAP70, FLI1, DOK5, ITM2A, PHLDA3, APLNR, CFHR3, NLRC3, GIMAP1, FBLN5, DARC, SLFN12L, RASGRP2, SELP, ACAP1, C7, HTR2B, TNXB, SAMD3, PDZD4	CTSL2, MFAP2, TMC5, BACE2

Genes in bold have not been previously reported for their prognostic value in hepatocellular carcinoma patients. HCC: Hepatocellular carcinoma; HCCDB: Integrative molecular database of hepatocellular carcinoma.